New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 7, 2013
07:13 EDTSVASinovac Biotech's hepatitis vaccine selected by Jiangsu Province
Sinovac Biotech has been selected by the Jiangsu Centers for Disease Control and Prevention to supply the company's inactivated hepatitis A vaccine, Healive, under the Expanded Program of Immunization in 2014 to the pediatric population in Jiangsu Province. Sinovac will supply 900,000 doses of Healive to Jiangsu province.
News For SVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
16:31 EDTSVASinovac Biotech reports Q3 EPS 0c, consensus (1c)
Reports Q3 revenue $17.1M, consensus $20.55M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use